they key to make RHT share price stay above 20c will be the next quarterly cash flow update, last quarter came in at:
current sales: $708k
overall cash flow: negative $334k
we used to be positive cash flow at times, but we now have more staffing/management/marketing cost etc as new CEO positioning us for more cash flow growth as previous FDA approvals haven’t quite translated to RHT bottom line, hence dumps as you mentioned
Ann: US FDA Clearance for LiverSmart, page-21
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.001(1.64%) |
Mkt cap ! $26.81M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.2¢ | 6.0¢ | $11.54K | 191.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 53320 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 134002 | 3 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.0¢ | 6.0¢ | 22823 | ||
| Last updated 15.43pm 17/06/2024 ? | |||||
| RHT (ASX) Chart |
